Burden of acute gastroenteritis, norovirus and rotavirus in a managed care population
- PMID: 24732307
- PMCID: PMC5396247
- DOI: 10.4161/hv.28704
Burden of acute gastroenteritis, norovirus and rotavirus in a managed care population
Abstract
This study assessed and described the episode rate, duration of illness, and health care utilization and costs associated with acute gastroenteritis (AGE), norovirus gastroenteritis (NVGE), and rotavirus gastroenteritis (RVGE) in physician office, emergency department (ED), and inpatient care settings in the United States (US). The retrospective analysis was conducted using an administrative insurance claims database (2006-2011). AGE episode rates were assessed using medical (ICD-9-CM) codes for AGE; whereas a previously published "indirect" method was used in assessing estimated episode rates of NVGE and RVGE. We calculated per-patient, per-episode and total costs incurred in three care settings for the three diseases over five seasons. For each season, we extrapolated the total economic burden associated with the diseases to the US population. The overall AGE episode rate in the physician office care setting declined by 15% during the study period; whereas the AGE episode rate remained stable in the inpatient care setting. AGE-related total costs (inflation-adjusted) per 100 000 plan members increased by 28% during the 2010-2011 season, compared with the 2006-2007 season ($832,849 vs. $1 068 116) primarily due to increase in AGE-related inpatient costs. On average, the duration of illness for NVGE and RVGE was 1 day longer than the duration of illness for AGE (mean: 2 days). Nationally, the average AGE-related estimated total cost was $3.88 billion; NVGE and RVGE each accounted for 7% of this total. The episodes of RVGE among pediatric populations have declined; however, NVGE, RVGE and AGE continue to pose a substantial burden among managed care enrollees. In conclusion, the study further reaffirms that RVGE has continued to decline in pediatric population post-launch of the rotavirus vaccination program and provides RVGE- and NVGE-related costs and utilization estimates which can serve as a resource for researchers and policy makers to conduct cost-effectiveness studies for prevention programs.
Keywords: acute gastroenteritis; duration of illness; health care cost; norovirus; rotavirus.
Figures
Similar articles
-
Costs of community-acquired pediatric rotavirus gastroenteritis in 7 European countries: the REVEAL Study.J Infect Dis. 2007 May 1;195 Suppl 1:S36-S44. doi: 10.1086/516716. J Infect Dis. 2007. PMID: 17539193
-
Multicenter prospective study on the burden of rotavirus gastroenteritis in children less than 3 years of age in Spain.BMC Infect Dis. 2016 Oct 10;16(1):549. doi: 10.1186/s12879-016-1890-7. BMC Infect Dis. 2016. PMID: 27724892 Free PMC article.
-
The Hidden Health and Economic Burden of Rotavirus Gastroenteritis in Malaysia: An Estimation Using Multiple Data Sources.Pediatr Infect Dis J. 2016 Jun;35(6):601-6. doi: 10.1097/INF.0000000000001129. Pediatr Infect Dis J. 2016. PMID: 27008464
-
Burden of community-acquired and nosocomial rotavirus gastroenteritis in the pediatric population of Western Europe: a scoping review.BMC Infect Dis. 2012 Mar 19;12:62. doi: 10.1186/1471-2334-12-62. BMC Infect Dis. 2012. PMID: 22429601 Free PMC article. Review.
-
Burden of rotavirus gastroenteritis in the pediatric population in Central and Eastern Europe: serotype distribution and burden of illness.Hum Vaccin. 2011 May;7(5):523-33. doi: 10.4161/hv.7.5.14819. Epub 2011 May 1. Hum Vaccin. 2011. PMID: 21422818 Free PMC article. Review.
Cited by
-
Characterization of viroplasm-like structures by co-expression of NSP5 and NSP2 across rotavirus species A to J.J Virol. 2024 Sep 17;98(9):e0097524. doi: 10.1128/jvi.00975-24. Epub 2024 Aug 28. J Virol. 2024. PMID: 39194242 Free PMC article.
-
Economic Burden of Acute Gastroenteritis among Members of Integrated Healthcare Delivery System, United States, 2014-2016.Emerg Infect Dis. 2024 May;30(5):968-973. doi: 10.3201/eid3005.230356. Emerg Infect Dis. 2024. PMID: 38666613 Free PMC article.
-
Economic Burden and Influencing Factors of Acute Gastroenteritis in China: A Population-Based Face to Face Survey in 2018.Front Public Health. 2022 Jun 3;10:905458. doi: 10.3389/fpubh.2022.905458. eCollection 2022. Front Public Health. 2022. PMID: 35769779 Free PMC article.
-
Norovirus and Other Viral Causes of Medically Attended Acute Gastroenteritis Across the Age Spectrum: Results from the Medically Attended Acute Gastroenteritis Study in the United States.Clin Infect Dis. 2021 Aug 16;73(4):e913-e920. doi: 10.1093/cid/ciab033. Clin Infect Dis. 2021. PMID: 34398953 Free PMC article.
-
Model estimates of hospitalization discharge rates for norovirus gastroenteritis in Europe, 2004-2015.BMC Infect Dis. 2021 Aug 5;21(1):757. doi: 10.1186/s12879-021-06421-z. BMC Infect Dis. 2021. PMID: 34353287 Free PMC article.
References
-
- Centers for Disease Control and Prevention. burden of norovirus illness and outbreaks [Internet]. Atlanta (GA): Centers for Disease Control and Prevention; c2012 [updated 2013 September 27; cited 2013 Jun 18]; [about 2 screens]. Available from: http://www.cdc.gov/norovirus/php/illness-outbreaks.html
-
- Dennehy PH, Vesikari T, Matson DO, Itzler RF, Dallas MJ, Goveia MG, DiNubile MJ, Heaton PM, Ciarlet M. Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen) Hum Vaccin. 2011;7:563–8. doi: 10.4161/hv.7.5.15406. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical